Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-05 · accession 0001209191-23-048473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-06 | 2023-09-05 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | F - Tax | $51.00 | -1,189 | 20.5K | -5% | -$60.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | F | D | 1,189 | $51.00 | 20,487 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. |